Analyst Price Target is $17.00
▲ +266.38% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Orchestra BioMed in the last 3 months. The average price target is $17.00, with a high forecast of $20.00 and a low forecast of $14.00. The average price target represents a 266.38% upside from the last price of $4.64.
Current Consensus is
Buy
The current consensus among 2 contributing investment analysts is to buy stock in Orchestra BioMed. This Buy consensus rating has held steady for over two years.